Univariate | Risk factors | P value | Odds ratio | 95% CI |
Age | > 65.5 years | 0.11 | 2.4 | 0.8–7.3 |
Gender | Male | 1.00 | 1.0 | 0.3–3.4 |
Past history of | ||||
Cardiovascular disease | Positive | 0.43 | 0.4 | 0.0–3.8 |
Hypertension | Positive | 0.75 | 0.8 | 0.3–2.6 |
Diabetes | Positive | 0.36 | 1.9 | 0.5–8.2 |
Pathological T stage | pT3, 4 | 0.68 | 0.7 | 0.1–3.8 |
Pathological N status | pN+ | 0.57 | 2.3 | 0.1–38.1 |
Hydronephrosis at 1 M | > low | 0.22 | 2.1 | 0.6–6.7 |
Neoadjuvant chemotherapy | received | 0.94 | 0.9 | 0.1–10.6 |
Preoperative eGFR | < 60 | 0.03 | 7.0 | 1.2–40 |
Postoperative eGFR at 1 M | < 60 | 0.00 | 7.7 | 2.2–27 |
Complications (any grade) | Positive | 0.53 | 1.5 | 0.4–4.8 |
Operative duration | > 294 | 0.04 | 3.4 | 1.1–10 |
Blood loss (g) | > 1380 | 0.11 | 2.4 | 0.8–7.3 |
Recurrence | Positive | 0.57 | 2.3 | 0.1–38.1 |
Multivariate | Risk factors | P value | Odds ratio | 95% CI |
Age | > 65.5 years | 0.03 | 1.2 | 1.1–1.5 |
Gender | Male | 0.03 | 0.7 | 0.5–0.9 |
Hydronephrosis at 1 M | > low | 0.36 | 0.4 | 0.7–1.1 |
Preoperative eGFR | < 60 | 0.25 | 3.7 | 0.4–34.0 |
Postoperative eGFR at 1 M | < 60 | 0.01 | 9.0 | 1.9–42.4 |
Operative duration | > 294 | 0.02 | 6.2 | 1.3–29.3 |